Arvydas Vanagunas

  • 1296 Citations
1980 …2019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Endoscopic ultrasound, Ulcer disease

Certifications and Licenses

Internal Medicine
Gastroenterology

Training Experience

1974Internship, Northwestern University, McGaw Medical Center
1976Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)
1980Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, University of Illinois - Chicago

… → 1969

Fingerprint Dive into the research topics where Arvydas Vanagunas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Parkinson Disease Medicine & Life Sciences
Pylorus Medicine & Life Sciences
Esophageal Perforation Medicine & Life Sciences
Gels Medicine & Life Sciences
Helicobacter pylori Medicine & Life Sciences
Neoadjuvant Therapy Medicine & Life Sciences
Gastrointestinal Hemorrhage Medicine & Life Sciences
Total Parenteral Nutrition Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2005 2016

Research Output 1980 2019

1 Citation (Scopus)

Reply to: DUOPA® is an Excellent Alternative Treatment but with Some Caveats

Burack, M., Aldred, J., Zadikoff, C., Vanagunas, A., Klos, K., Bilir, B., Fernandez, H. H. & Standaert, D. G., Jan 1 2019, In : Movement Disorders Clinical Practice.

Research output: Contribution to journalLetter

4 Citations (Scopus)

Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners

Burack, M., Aldred, J., Zadikoff, C., Vanagunas, A., Klos, K., Bilir, B., Fernandez, H. H. & Standaert, D. G., Jul 1 2018, In : Movement Disorders Clinical Practice. 5, 4, p. 383-393 11 p.

Research output: Contribution to journalReview article

Parkinson Disease
Gels
Patient Care
Therapeutics
Education
3 Citations (Scopus)

Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease

Fernandez, H. H., Boyd, J. T., Fung, V. S. C., Lew, M. F., Rodriguez, R. L., Slevin, J. T., Standaert, D. G., Zadikoff, C., Vanagunas, A., Chatamra, K., Eaton, S., Facheris, M. F., Hall, C., Robieson, W. Z., Benesh, J. & Espay, A. J., Jun 1 2018, In : Movement Disorders. 33, 6, p. 928-936 9 p.

Research output: Contribution to journalArticle

Parkinson Disease
Gels
Safety
Levodopa
Gastrostomy
1 Citation (Scopus)

Phlegmonous Gastritis: A Previously Unknown Complication of Listeria monocytogenes Infection

Kelly, S. G., Vanagunas, A. & Dinh, M. H., Sep 1 2016, In : Infectious Diseases in Clinical Practice. 24, 5, p. e17-e19

Research output: Contribution to journalArticle

Listeriosis
Listeria monocytogenes
Gastritis
Streptococcus
Stomach
260 Citations (Scopus)

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: A randomised, controlled, double-blind, double-dummy study

Olanow, C. W., Kieburtz, K., Odin, P., Espay, A. J., Standaert, D. G., Fernandez, H. H., Vanagunas, A., Othman, A. A., Widnell, K. L., Robieson, W. Z., Pritchett, Y., Chatamra, K., Benesh, J., Lenz, R. A. & Antonini, A., Feb 1 2014, In : The Lancet Neurology. 13, 2, p. 141-149 9 p.

Research output: Contribution to journalArticle

Double-Blind Method
Parkinson Disease
Gels
Gastric Bypass
Dyskinesias